Oleg Movchan is Chief Executive Officer and Director of Enfusion, Inc. (ENFN). The company reported total compensation of $1,455,190 for fiscal year 2023.
| Salary | $650,025 |
|---|---|
| Bonus | — |
| Stock awards | $370,401 |
| Option awards | $250,000 |
| Non-equity incentive plan | $180,600 |
| Pension and non-qualified deferred compensation | — |
| All other compensation | $4,164 |
| Total | $1,455,190 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Enfusion, Inc. filed April 26, 2024, accession 0001558370-24-005911.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2023 | Chief Executive Officer and Director | $650,025 | — | $370,401 | $250,000 | $180,600 | — | $4,164 | $1,455,190 |
| FY2022 | Chief Executive Officer and Director | $235,507 | $219,041 | $1,202,500 | $0 | $0 | $0 | $0 | $1,657,048 |
Totals as disclosed in each year's own compensation disclosure for Enfusion, Inc..
| Named executive officer | Role | FY2023 total |
|---|---|---|
| Neal Pawar | Chief Operating Officer | $2,616,626 |
| Oleg Movchan this page | Chief Executive Officer and Director | $1,455,190 |
| Bradley Herring | Chief Financial Officer | $1,106,890 |
The company's named executive officers for fiscal year 2023, and what it reported for each. See the full Enfusion, Inc. compensation brief.
Oleg Movchan's compensation sits inside Enfusion, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.